Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Expert Opinion on Drug Safety|August 23, 2016
The safety and tolerability of the second-line injectable antituberculosis drugs in childrenAnthony J Garcia-Prats, H Simon Schaaf, Anneke C Hesseling
Journal of the International AIDS Society|December 8, 2015
Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected childrenHelena Rabie, Lisa Frigati, Anneke C Hesseling, et al.
Pediatric Pulmonology|December 17, 2013
GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot studyElisabetta Walters, Pierre Goussard, Corne Bosch, et al.
Thorax|September 26, 2013
High treatment success in children treated for multidrug-resistant tuberculosis: an observational cohort studyJames A Seddon, Anneke C Hesseling, Peter Godfrey-Faussett, et al.
Journal of the Pediatric Infectious Diseases Society|October 31, 2022
Tuberculosis in Children Living With HIV: Ongoing Progress and ChallengesBryan J Vonasek, Helena Rabie, Anneke C Hesseling, et al.
Plos One|November 5, 2016
Tuberculosis Disease during Pregnancy and Treatment Outcomes in HIV-Infected and Uninfected Women at a Referral Hospital in Cape TownAdrie Bekker, Hendrik S Schaaf, Heather R Draper, et al.
Tuberculosis (Edinburgh, Scotland)|January 7, 2014
Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendationsAnthony J Garcia-Prats, Penelope C Rose, Anneke C Hesseling, et al.
Current Opinion in Infectious Diseases|April 23, 2014
Managing multidrug-resistant tuberculosis in children: review of recent developmentsH Simon Schaaf, Anthony J Garcia-Prats, Anneke C Hesseling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2011
Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcomeJames A Seddon, Anneke C Hesseling, Marianne Willemse, et al.
Plos Medicine|August 16, 2019
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected personsAmita Gupta, Michael D Hughes, Anthony J Garcia-Prats, et al.
Pageof 21